BUSINESSCNBC TOP
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk has filed a lawsuit against Eli Lilly, accusing the company of running misleading GLP-1 advertisements. The lawsuit seeks to halt these ads and mandate corrective advertising.
Related Signal
Adjacent reporting
- Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
- STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
- Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
- Lawsuit filed by AG Ellison against e-cigarette manufacturer Loon
- Publishers accuse Google of stealing copyrighted content in new lawsuit